ProQR Therapeutics N.V.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PRQR | EDIT | PRME | DTIL | SCTX | ALEC | |
|---|---|---|---|---|---|---|
| Market cap | 228.61M | 422.35M | 654.77M | 180.24M | 391.32M | 232.25M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -3.4 | -3.7 | -4.1 | -3.5 | -5.7 | -2.8 |
| Price/book | 2.6 | 4.0 | 16.0 | 3.8 | -0.3 | -23.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −28.82% | −18.54% | −29.38% | +20.86% | +11.60% | −30.43% |
| Today | −0.61% | −5.17% | −9.52% | −2.83% | −2.36% | 0.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All PRQR news ›Financial Comparison: ProQR Therapeutics (NASDAQ:PRQR) vs. Beam Therapeutics (NASDAQ:BEAM)
Posted by Danessa Lincoln on Oct 11th, 2026 ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) and Beam Therapeutics (NASDAQ:BEAM – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the…
ProQR Therapeutics N.V. - Ordinary Shares (PRQR) Stock Price, News, Quote & History
FinancialContent ProQR Therapeutics N.V. - Ordinary Shares (PRQR) About ProQR Therapeutics N.V. - Ordinary Shares (PRQR) ProQR Therapeutics is a biotechnology company focused on developing innovative RNA-based therapies to treat genetic…
ProQR Therapeutics (NASDAQ:PRQR) Stock Price Target Cut by HC Wainwright
ProQR Therapeutics (NASDAQ:PRQR - Get Free Report) had its price target dropped by investment analysts at HC Wainwright to $8.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has a "buy" rating on…
Chardan Capital maintains Buy rating on ProQR Therapeutics, $3 price target
Chardan Capital maintained their Buy rating on ProQR Therapeutics's stock with a price target of $3.00. The price target implies an upside of 80.7% from the Sep 30 close of $1.66. Key takeaways from the analyst note Strong Clinical…
ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call - Slideshow (NASDAQ:PRQR) 2026-09-30
2026-09-30. The following slide deck was published by ProQR Therapeutics N.V.
ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call Transcript
ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call September 30, 2026 11:00 AM EDTCompany ParticipantsSarah Kiely - Vice President of Investor...
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
themarketsdaily.com4
-
seekingalpha.com2
-
financialcontent.com1
-
marketbeat.com1
-
tradingview.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.